The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer
Delphine Le Corre(Centre de Recherche des Cordeliers), Sophie Mouillet‐Richard(Centre National de la Recherche Scientifique)
Cited by 50
Related Papers
Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
|Journal of Clinical Oncology|2010|169
Pathogenic prions deviate PrPC signaling in neuronal cells and impair A-beta clearance
|Cell Death and Disease|2013|29
A PrPC-caveolin-Lyn complex negatively controls neuronal GSK3β and serotonin 1B receptor
|Scientific Reports|2014|29